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Association between polymorphisms of the renin
angiotensin system and carotid stenosis
Elena Sticchi, BS, PhD,a,b Ilaria Romagnuolo, BS,a,c Francesco Sofi, MD, PhD,a Giovanni Pratesi, MD,d
Raffaele Pulli, MD,d Carlo Pratesi, MD,d Rosanna Abbate, MD,a and Cinzia Fatini, MD, PhD,a Florence, Italy
Objective: Carotid stenosis is a common manifestation of systemic atherosclerosis. Apart from traditional risk factors,
genetic determinants, such as polymorphisms of the renin angiotensin system (RAS), may be relevant in modulating the
atherosclerotic process leading to carotid stenosis. In this study, we investigated the role of angiotensin-converting
enzyme (ACE) I/D and -240A>T, angiotensinogen (AGT) M235T, and angiotensin type 1 receptor (AGTR1) 1166A> C
polymorphisms in modulating the susceptibility to the disease.
Methods: Eight hundred twenty-one consecutive patients with severe carotid stenosis (>70%) and 847 control subjects
were investigated.
Results: A significant difference in genotype distribution (P < .0001) and allele frequency (P < .0001) between patients
and controls for the ACE I/D polymorphism, but not for the other single-nucleotide polymorphisms investigated, was
observed. The ACE D allele frequency was significantly higher in patients without traditional risk factors in comparison
with that observed in those with at least one risk factor (0.71 vs 0.61; P .04). The ACED allele significantly influenced
carotid stenosis under dominant, recessive, and additive model of inheritance at both univariate (P < .0001) and
multivariate analysis (P< .0001). When the combined effect of RAS unfavorable alleles was considered, patients carrying
less than three alleles had a lower risk of carotid stenosis (odds ratio [OR], 0.79 [0.63-0.99]; P  .05), while carriers of
more than four unfavorable alleles had an increased risk (OR, 1.44 [1.12-1.84]; P  .004), in comparison with subjects
carrying three or four unfavorable alleles. ACE D allele frequency was similar in patients with and without additional
atherosclerotic localizations (0.61 vs 0.62, respectively).
Conclusions: Our findings evidence a role for ACE I/D polymorphism in influencing the susceptibility to carotid steno-
sis, even in the absence of traditional risk factors. Interestingly, our findings provided further information concerning the
role of this polymorphism in modulating the atherosclerotic process apart from its different localizations. ( J Vasc Surg
2011;54:467-73.)
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(Atherosclerosis is a widespread process with a strong
heritable component and represents the final common
pathway affecting blood vessels in the brain, coronary cir-
culation, and peripheral circulation. Carotid atherosclerosis
is a common manifestation of systemic atherosclerosis as-
sociated with an increased risk of vascular events.
The renin angiotensin system (RAS) plays a central role
in the pathogenesis of atherosclerotic disease as angiotensin
II activates intracellular signaling pathways, thus promot-
ing atherothrombosis through inflammation, endothelial
dysfunction, growth, altered fibrinolysis, and enhanced
LDL oxidation.1 Functional polymorphisms such as angio-
tensinogen (AGT) M235T, angiotensin type 1 receptor
From the Department of Medical and Surgical Critical Care, Thrombosis
Centre, University of Florence, Azienda Ospedaliero-Universitaria Care-
ggia; Fondazione Don Carlo Gnocchi ONLUS, Centro S. Maria degli
Ulivi-IRCCSb; Fiorgen Foundationc; and Unit of Vascular Surgery, Uni-
versity of Florence, Azienda Ospedaliero-Universitaria Careggi.d
Supported by grants from Ente Cassa di Risparmio di Firenze to Fiorgen
Foundation, Florence, Italy.
Competition of interest: none.
Reprint requests: Cinzia Fatini, MD, Department of Medical and Surgical
Critical Care, University of Florence, VialeMorgagni 85, 50134 Florence,
Italy (e-mail: cinziafatini@hotmail.com).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00P
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.01.039AGTR1) 1166A  C, angiotensin-converting enzyme
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omponents modulate the atherosclerotic process.2 In par-
icular, AGTM235T polymorphism, by influencing angio-
ensinogen concentration,3 has been associated with hyper-
ension3 and myocardial infarction,4 but data from
iterature did not demonstrate its role in cerebrovascular
isease.5-7 TheACE I/D polymorphism has been reported
o modulate angiotensin II concentrations,8,9 and an in-
reased mRNA expression in white blood cells from sub-
ects carrying the ACE D allele has been demonstrated.10
his polymorphism modulates atherosclerosis at different
ocalizations such as coronary artery disease,11 peripheral
rterial disease (PAD),12,13 and abdominal aortic aneurysm
AAA).14 Conflicting data concerning its role in cerebro-
ascular disease are reported.15-17 The ACE - 240A  T
olymorphism has been investigated in cardiovascular dis-
ase18 and PAD,13 but no information in carotid athero-
clerosis is available.
Finally, the AGTR1 1166A  C polymorphism has
een demonstrated to influence the predisposition to
AD,11 aortic stiffness,19 and vascular reactivity,20 but
nly one study on cerebrovascular disease is reported.7
As we previously investigated the possible influence of
CE (I/D, -240AT), AGT (M235T) and AGTR1
1166A  C) RAS polymorphisms on CAD, AAA, and
AD, we aimed this study to analyze the single and com-
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predisposition to carotid atherosclerosis.
METHODS
The study population consisted of 835 unrelated con-
secutive patients admitted to the Unit of Vascular Surgery
of the University of Florence to be evaluated for surgical
intervention. Fourteen patients refused to consent to the
genetic analysis, so the final study group included 821
patients.
Carotid stenosis was assessed by duplex scanning with
color-coded echo flow imaging and confirmed by angio
computed tomography, according to the North American
Symptomatic Carotid Endarterectomy Trial criteria.21 All
patients had severe (defined by a stenosis 70%) carotid
stenosis. Preoperative neurological symptoms, defined as
ipsilateral cerebrovascular events during 180 days within
the intervention, were recorded in 292 patients; the re-
maining patients were asymptomatic. Patients with non-
hemispheric symptoms were considered to be asymptom-
atic. Thirty-one of 821 patients (3.8%) suffered fromAAAs,
72 (8.8%) from CAD, and 179 (21.8%) from PAD.
All patients underwent a clinical cardiological evalua-
tion, electrocardiogram (ECG), and echocardiogram and
peripheral arteries echo color Doppler analysis. In patients
referring symptoms, possibly related to ischemic heart dis-
ease, further investigations have been performed (ECG on
exercise stress testing, myocardial scintigraphy, and coro-
nary angiography).
We have enrolled 982 apparently healthy subjects re-
cruited from blood donors and from partners or friends of
patients, in order to have a control group. Expert physicians
performed, in the frame of a physical examination, a de-
tailed interview addressed to personal and familial history in
order to identify disease-free controls and to exclude sub-
jects who were suspected of having any form of vascular
disease. We have excluded 135 subjects suspected to have
had any form of vascular disease; therefore, 847 apparently
healthy subjects represented the control group.
Based on information from physical examinations and
detailed interviews, we have investigated the presence/
absence of traditional cardiovascular risk factors. The sub-
jects were considered to have hypertension if they had been
diagnosed as hypertensives according to the guidelines of
European Society of Hypertension/European Society of
Cardiology22 or were taking antihypertensive drugs. Dys-
lipidemia was defined according to the Third Report of the
National Cholesterol Education Program23 and diabetes in
agreement with the American Diabetes Association.24
Smokers were defined as current or recent (ex-smokers who
stopped less than 5 years previously) smokers.
A positive family history was defined as the presence of
at least one first-degree relative who had developed cardio-
vascular disease before the age of 55 years for men and 65
years for women.
Consanguineous subjects were excluded; patients and
controls were Caucasian and drawn from the same area
(Central Italy); all subjects gave informed consent, and the (tudy complies with the Declaration of Helsinki and was
pproved by the local ethic committee of the Faculty of
edicine, University of Florence.
Detection of RAS polymorphisms. Genomic DNA
xtraction was performed from peripheral blood leukocytes
y using QIAmp Blood Kit (Qiagen, Hilden, Germany).
RAS polymorphisms [ACE I/D (rs4340; NT_
10783.14: g.20217903_20217904ins5), ACE - 240A 
(rs4291;NT_010783.14: g.20206205T A),AGTR1
166A  C (rs5186; NT_005612.15: g.54955134A 
), AGT M235T (rs699; NT_004559.13: g.7047947A 
)] have been genotyped according to previously reported
ethods.11,25
Statistical analysis. Statistical analysis was performed
y using the SPSS (Statistical Package for Social Sciences,
hicago, Ill) software for Windows (Version 11.5). Con-
inuous variables were expressed as median (range), and the
onparametric Mann-Whitney test for unpaired data was
sed for comparison between single groups, as appropriate.
he 2 test was used to test for deviation of genotype
istribution from Hardy-Weinberg equilibrium, to evalu-
te the differences in genotype distribution and allele fre-
uency, and to analyze differences in the prevalence of
raditional risk factors between patients and controls.
The number of subjects studied was sufficient to detect,
ith a statistical power of 90% (  0.9) and significance
alue of 0.05 (), absolute differences in ACE D allele
requencies between patients and controls. The Bonferroni
orrection was used for multiple testing (the four candidate
olymorphisms were treated as four independent statistical
ests) by multiplying the nominal P value of each test by
he number of tests conducted.
The association between ACE, AGTR1, and AGT
olymorphisms and carotid stenosis was assessed by using
ogistic regression analysis under dominant, recessive, and
dditive genetic model of inheritance.26 The dominant
enetic model compares individuals with one or more
olymorphic alleles with a baseline group with no polymor-
hic alleles (eg,ACEDD ID vs II). The recessive genetic
odel compares homozygous genotype for rare variant
ith the combined heterozygous and homozygous geno-
ypes for the wild-type allele (eg, ACE DD vs IDII),
orming the baseline group. The additive genetic model
ssumes that there is a linear gradient in the risk among
D, ID, and II genotypes (II genotype baseline). This is
quivalent to a comparison of the D allele versus the I allele
baseline). Cardiovascular traditional risk factors and vari-
bles as age and gender were included into the multivariate
odel. Odds ratio (OR) with 95% confidence interval was
etermined. In order to investigate the risk of disease for
ombined effect of variant rare alleles, the study population
as divided into three subgroups according to tertiles of
heir distributions: a low-risk group (0-2 alleles), an inter-
ediate-risk group (3-4 alleles), and a high-risk group (4
lleles).
Statistical significance was accepted at P value .05
two-sided P value).
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We investigated 568 males, median age 72 years
(range, 45 to 86 years), 253 females, median age 73 years
(range, 25 to 88 years), and 847 apparently healthy subjects
(550 males, median age 70 years [range, 24-83 years], and
297 females, median age 70 years [range, 22-83 years]).
Demographic, clinical, and genetic characteristics of the
study population are reported in Table I. Traditional risk
factors were significantly higher in patients than in controls.
No deviation from the expected genotype proportion pre-
dicted byHardy-Weinberg equilibriumwas observed for all
the polymorphisms analyzed. A significant difference for
ACE I/D genotype distribution and allele frequency be-
tween patients and controls was observed, and a higher,
even if not significant, ACE -240T allele frequency in
patients than in controls was found. As concerning the
other single-nucleotide polymorphisms investigated, no
significant differences between patients and controls were
evidenced (Table I).
At both univariate andmultivariate analysis, theACED
Table I. Demographic, clinical, and genetic characteristics
Variable
Age (years)a
Males, n (%)
Hypertension, n (%)
Dyslipidemia, n (%)
Diabetes, n (%)
Smoking habits, n (%)
Family history of cardiovascular disease, n (%)
AAA, n (%)
CAD, n (%)
PAD, n (%)
RAS polymorphisms
Genotypeb Allele
ACE
DD
ID
II
D
-240TT
-240AT
-240AA
-240T
AGT
235TT
235MT
235MM
235T
AGTR1
1166CC
1166AC
1166AA
1166C
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; PAD, pe
P values in bold indicate P  .05.
aMedian (range).
bGenotypes are expressed as n (%).allele was significantly associated with the disease under hominant, recessive, and additive model of inheritance
Table II); at univariate analysis, but not after adjustment
or traditional risk factors, theACE -240T allele was signif-
cantly associated with the disease under dominant model
f inheritance; no association betweenAGTR1 1166C and
GT 235T alleles and the disease at both univariate and
ultivariate analysis, was found (Table II).
In smokers and diabetic patients, the ACE D allele in-
reased the predisposition to the disease under all genetic
odels of inheritance (Table III). On the other hand, the
ther RAS rare variants did not modify the risk in hyperten-
ives, diabetics, smokers, and dyslipidemics (data not shown).
Sixty-three out of 821 (7.7%) patients reported no
raditional risk factors; in these patients, the frequency of
CED, but not of the other rare variants, was significantly
igher than in patients with at least one risk factor (0.71 vs
.61; P  .04); moreover, ACE D allele frequency was
ignificantly different between patients and controls with-
ut traditional risk factors (0.71 vs 0.50; P  .0001).
Two hundred ninety-two out of 821 patients (35.6%)
he study population
Patients (n  821) Controls (n  847) P
72 (25-88) 69 (19-83) .06
568 (69) 550 (65) .07
484 (59) 162 (19) <.0001
332 (40) 153 (18) <.0001
128 (16) 41 (5) <.0001
380 (46) 159 (19) <.0001
101 (12) 76 (9) .03
31 (4) — —
72 (9) — —
179 (22) — —
318 (39) 217 (26)
395 (48) 431 (51)
108 (13) 199 (24) <.0001
0.63 0.51 <.0001
140 (17) 131 (16)
405 (49) 390 (46)
276 (34) 326 (39) .1
0.42 0.39 .06
166 (20) 153 (18)
407 (50) 425 (50)
248 (30) 269 (32) .5
0.45 0.43 .3
56 (7) 65 (8)
357 (44) 364 (43)
408 (50) 418 (49) .8
0.28 0.29 .7
al arterial disease; RAS, renin-angiotensin system.of t
ripherad symptomatic carotid stenosis (140 transient ischemic
p
a
P
t
t
g
g
a
g habi
JOURNAL OF VASCULAR SURGERY
August 2011470 Sticchi et alattacks, 97 minor strokes, and 55 major strokes); no differ-
ence in ACE D allele frequency between symptomatic and
asymptomatic patients (0.61 vs 0.62, respectively) and
among patients with transient ischemic attack (0.60), mi-
nor (0.61), and major stroke (0.61) was observed.
Five hundred forty-nine out of 821 patients (66.9%)
showed no additional atherosclerotic localizations (isolated
carotid stenosis); in this subgroup, theACEDallele frequency
was not different from that observed in patients with other
Table II. Univariate and multivariate analysis for renin-an
Univar
Dominant model
OR(95% CI) P O
ACE D 2.03 (1.57-2.62) <.0001a 1.8
ACE-240 T 1.24 (1.01-1.51) .04b 1.1
AGTR1 1166C 0.97 (0.81-1.19) .9 0.8
AGT 235T 1.07 (0.87-1.32) .5 1.1
Multivar
Dominant model
OR (95% CI) P O
ACE D 1.98 (1.45-2.70) <.0001a 1.9
ACE-240 T 1.12 (0.88-1.43) .4
AGTR1 1166C —
AGT 235T —
CI, Confidence interval; OR, odds ratio.
P values in bold indicate P  .05.
Bonferroni correction:
aP  .0001; bP  .2; cadjusted for age, sex, hypertension, diabetes, smokin
Table III. Univariate and multivariate analysis for the inte
factors
Univariate analysis OR(95% CI) P
Hypertension 6.07 (4.87-7.57) <.0001
Smoking habit 3.73 (2.99-4.65) <.0001
Diabetes 3.63 (2.52-5.24) <.0001
Dyslipidemia 3.08 (2.46-3.85) <.0001
Dominant model
ACE D 2.03 (1.57-2.62) <.0001
ACE Da hypertension 5.69 (4.52-7.18) <.0001
ACE Da smoking habit 4.45 (3.50-5.67) <.0001
ACE Da diabetes 4.11 (2.74-6.16) <.0001
ACE Da dyslipidemia 3.27 (2.56-4.16) <.0001
Multivariate analysisb
ACE Da hypertension 5.18 (3.99-6.72) <.0001
ACE Da smoking habit 4.96 (3.73-6.61) <.0001
ACE Da diabetes 3.57 (2.19-5.80) <.0001
ACE Da dyslipidemia 2.84 (2.13-3.80) <.0001
CI, Confidence interval; OR, odds ratio.
P values in bold indicate P  .05.
aContemporary presence of ACE D allele and traditional risk factors.
bAdjusted for age, gender, and traditional risk factors.atherosclerotic localizations (0.62 vs 0.61, respectively). 3RAS allelic burden. A significant difference between
atients and controls according to the number of unfavor-
ble alleles (ranging from 0 to 8) was found (2  25.65;
 .001). In order to search for the combined effect of
hese alleles, both patients and controls were divided into
hree subgroups according to tertiles of their distribution:
roup A with less than three unfavorable alleles (n 464),
roup B with three or four unfavorable alleles (n  832),
nd group C with more than four unfavorable alleles (n 
nsin system polymorphisms
nalysis
Recessive model Additive model
% CI) P OR (95% CI) P
9-2.26) <.0001a 2.7 (2.02-3.61) <.0001a
7-1.46) .4 1.26 (0.95-1.68) .1
1-1.28) .5 0.88 (0.60-1.29) .5
0-1.47) .3 1.18 (0.89-1.57) .3
nalysisc
Recessive model Additive model
5% CI) P OR (95% CI) P
4-2.55) <.0001a 2.81 (1.97-4.00) <.0001a
—
—
—
t, and dyslipidemia.
on between ACE I/D polymorphism and traditional risk
R(95% CI) P OR(95% CI) P
Recessive model Additive model
(1.49-2.26) <.0001 2.70 (2.02-3.61) <.0001
(4.13-8.64) <.0001 7.21 (4.89-10.64) <.0001
(3.60-7.64) <.0001 6.04 (4.07-8.96) <.0001
(3.35-16.57) <.0001 7.42 (3.32-16.60) <.0001
(2.09-4.22) <.0001 3.15 (2.18-4.56) <.0001
(3.5-7.91) <.0001 6.36 (4.13-9.78) <.0001
(4.23-9.98) <.0001 7.24 (4.58-11.47) <.0001
(2.31-14.16) <.0001 5.51 (2.21-13.78) <.0001
(1.66-3.84) <.0001 2.47 (1.58-3.85) <.0001giote
iate a
R(95
3 (1.4
2 (0.8
8 (0.6
5 (0.9
iate a
R (9
8 (1.5
—
—
—racti
O
1.83
5.97
5.24
7.45
2.97
5.26
6.49
5.71
2.5272; Fig).
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Volume 54, Number 2 Sticchi et al 471By considering group B (3-4 unfavorable alleles), the
reference group, subjects with less than three alleles (groupA)
showed a lower risk of carotid atherosclerosis, while subjects
withmore than four alleles (groupC) showed an increased risk
(Fig). By comparing the two extreme groups (C vs A group),
subjects with more than four alleles showed a significantly
higher risk of carotid stenosis at both univariate and multivar-
iate analysis (OR, 1.81; 95% CI, 1.37-2.38; P  .0001; OR,
2.04; 95% CI, 1.46-2.86; P .0001, respectively).
DISCUSSION
This study provides evidence that polymorphisms in
genes encoding for components of the renin angiotensin
system are associated with the predisposition to carotid
atherosclerosis. Most importantly, in the absence of tradi-
tional risk factors, and in subjects carrying more than four
genetic rare variants. These results suggest that, beyond
single polymorphisms, allele-allele interactions may have a
synergistic impact on atherosclerotic process leading to
carotid atherosclerosis.
These novel findings strengthen the well-known effect
of RAS in modulating the atherosclerotic process and sup-
port the impact of the combined effect of several common
susceptibility polymorphisms in identifying patients at dif-
ferent risk of developing atherosclerosis.
Interestingly, in this study we observed thatACED allele
frequency was similar in patients with isolated carotid stenosis
and with other atherosclerotic localizations in addition to
carotid stenosis. Present findings and other previous studies
evidence that ACE D allele frequency is similar among sub-
groups of patients suffering from atherosclerosis at different
anatomical localizations, thus strengthening the role of the
renin angiotensin system and in particular, theACED allele, in
modulating atherosclerotic process (Table IV).
To date, there is good evidence from experimental and
clinical studies that RAS, via its active peptide angiotensin
Fig. Odds ratio for carotid stenosis in groups A, B, and C,
stratified on the basis of number of unfavorable alleles. Group B
(3-4 unfavorable alleles), representing the 49.9% of the whole
population, is considered as reference group.II, may contribute to atherosclerosis development and Arogression: data from literature documented an associa-
ion between RAS candidate genes and coronary artery
isease,27 abdominal aortic aneurysms,28 PAD,12 and cere-
rovascular disease.29 In particular, theACE I/D polymor-
hism, the most widely studied polymorphism among RAS
olymorphisms, has been reported to be a prognostic factor
or cerebrovascular events in patients with carotid athero-
clerosis,16 but few data concerning the role of the other
AS polymorphisms in carotid stenosis are available.6,7
In the present study, we observed that the ACE gene is
ble to influence the risk of carotid atherosclerosis in the
bsence of traditional risk factors. The relevance of this
atum might be explained by increased angiotensin II
evels, which are primarily modulated by ACE I/D poly-
orphism, by affecting the atherosclerotic process, inde-
endently of the well-known cardiovascular risk factors.
eally, among polymorphisms in RAS candidate genes, the
CE I/D polymorphism is relevant due to its functional
ole, and the mechanisms underlying the apparent associa-
ion between theACE gene and atherosclerosis are intrigu-
ng. The ACE I/D polymorphism is known to be respon-
ible for 47% of the total phenotypic variance of serum
CE,8 even if data derived from an in vitro assay suggested
hat the ACE intron 16 sequence by itself had no effect in
egulating transcription.30 This datum might suggest that
CE level variability is referred to another locus in linkage
isequilibrium with the I/D polymorphism. Actually, ex-
erimental data from ACE gene expression analysis evi-
enced that the ACE D allele was associated with higher
CE mRNA levels.10
Our findings did not demonstrate a role for AGT and
GTR1 polymorphisms in modulating carotid stenosis;
hese results are in keeping with other studies that evaluated
heir role as markers in carotid stenosis7 and ischemic
erebrovascular disease.6
Of interest, our study evidenced that the contemporary
resence of several unfavorable alleles represents a marker
f atherosclerotic risk, thus possibly suggesting an allelic
urden able to influence the susceptibility to the disease.
This study suffers from these limitations: first, the lack
f information concerning intima-media thickness (IMT)
easurement; data from literature reported a positive rela-
ionship between ACE I/D polymorphism and common
arotid IMT15; nevertheless, recently it has been demon-
trated that despite IMT being predictive for cardiovascular
nd points, it did not consistently improve the risk classifi-
ation of subjects.31 Second, the study did not provide data
oncerning intermediate phenotypes, which may result
rom RAS polymorphisms, thus not revealing the mecha-
isms linking the genetic variants and the disease. Finally,
he control group consisted of subjects with no clinical
vidence of atherosclerotic disease, whereas the optimal
omparable group would be represented by atherosclerotic
ubjects with no carotid stenosis. Moreover, some controls
ay still have carotid artery disease without any imaging
creening of controls.
In conclusion, in this study, we demonstrated that the
CE I/D polymorphism is associated with carotid athero-
11
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1
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factors, and provided evidence of a relationship between
multiple unfavorable RAS genetic variants and the risk of
disease. We are aware of the evidence from our results that
carotid stenosis patients should not be screened for RAS
polymorphisms; on the other hand, as carotid stenosis is a
polygenic disease, data from the present study might con-
tribute to highlight the role of candidate genes in modu-
lating the susceptibility to the disease. This study may have
a pathophysiological relevance by evidencing the contribu-
tion of RAS genes in the atherosclerotic process, as we
previously demonstrated, and our results might suggest
that in the future, it will be possible to apply the knowledge
gained by genetic analyses to better tailor and optimize the
therapy in atherosclerotic patients.
Further studies investigating a larger number of genetic
markers on larger samples are needed to confirm our results,
and replication of our findings in other populations would
further strengthen the claim of causality for RAS unfavorable
alleles and increased susceptibility to carotid stenosis.
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